Form 4: Nuvalent Director Joseph Pearlberg Reports Acquisition of Stock and Options
SEC Form 4 Filing
Director Joseph Pearlberg reports acquisition of Nuvalent, Inc. Class A Common Stock and stock options.
Summary
- Joseph Pearlberg, a director at Nuvalent, Inc., filed a Form 4 detailing changes in beneficial ownership.
- On June 12, 2024, Pearlberg acquired 2,499 shares of Class A Common Stock under restricted stock units (RSUs) at $0.00.
- These RSUs vest in full on the earlier of June 12, 2025, or the date of Nuvalent, Inc.'s next annual meeting of stockholders, contingent upon continued service.
- Pearlberg also acquired options to buy 3,789 shares of Class A Common Stock at an exercise price of $80.03.
- These options vest in full on the earlier of June 12, 2025, or the date of Nuvalent, Inc.'s next annual meeting of stockholders, contingent upon continued service.
- Following these transactions, Pearlberg directly owns 2,499 shares of Class A Common Stock and options for 3,789 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock and option acquisition by a director. The vesting requirements suggest a continued commitment.
Positives
- The acquisition of stock and options by a director could be seen as a positive sign, indicating confidence in the company's future.
Future Outlook
The vesting of the RSUs and stock options is contingent upon continued service to Nuvalent, Inc., suggesting an ongoing commitment from the director.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely watched by investors for insights into management's perspective on the company's stock.
Stakeholder Impact
- The acquisition of shares and options by a director can influence investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/12/2024 | Date of transaction: Acquisition of stock and options |
| 06/12/2025 | Vesting date for RSUs and stock options (or earlier date of next annual meeting) |
| 06/14/2024 | Date of Form 4 signature |
| 06/12/2034 | Expiration date of stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.